[1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975. doi: 10.1002/ejhf.592.10.1002/ejhf.59227207191]Search in Google Scholar
[2. Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557–573. doi: 10.1016/j.jacc.2008.10.041.10.1016/j.jacc.2008.10.04119215829]Search in Google Scholar
[3. Ross JS, Chen J, Lin Z, et al. Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail. 2010;3:97–103. doi: 10.1161/CIRCHEARTFAILURE.109.885210.10.1161/CIRCHEARTFAILURE.109.885210283081119903931]Search in Google Scholar
[4. Gheorghiade M, Bonow RO. Heart failure: early follow-up after hospitalization for heart failure. Nat Rev Cardiol. 2010;7:422–424. DOI: 10.1038/nrcardio.2010.102.10.1038/nrcardio.2010.10220657609]Search in Google Scholar
[5. Gheorghiade G, Follath F, Ponikowski P, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12(5):423-433. doi: 10.1093/eurjhf/hfq045.10.1093/eurjhf/hfq04520354029]Search in Google Scholar
[6. Gargani L. Lung ultrasound: a new tool for the cardiologist. Cardiovasc Ultrasound. 2011;9:6-13. DOI: 10.1186/1476-7120-9-6.10.1186/1476-7120-9-6305929121352576]Search in Google Scholar
[7. Gargani L, Volpicelli G. How I do it: Lung ultrasound. Cardiovasc Ultrasound. 2014;12:25. doi: 10.1186/1476-7120-12-25.10.1186/1476-7120-12-25409892724993976]Search in Google Scholar
[8. Metra M, Nodari S, Parrinello G. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Eur J Heart Fail. 2007;9(8):776-786. DOI: 10.1016/j.ejheart.2007.05.007.10.1016/j.ejheart.2007.05.00717573240]Search in Google Scholar
[9. Stienen S, Salah K, Eurlings LWM, et al. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro a brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels? Eur J Heart Fail. 2015;17(9):936-944. doi: 10.1002/ejhf.320.10.1002/ejhf.32026222618]Search in Google Scholar
[10. Manson WC, Bonz JW, Carmody K, et al. Identification of Sonographic B-lines with Linear Transducer Predicts Elevated B-Type Natriuretic Peptide Level. West J Emerg Med. 2011 Feb; 12(1): 102–106.]Search in Google Scholar
[11. Coiro S, Rossignol P, Ambrosio G, et al. Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail. 2015;17(11):1172-1181. doi: 10.1002/ejhf.344.10.1002/ejhf.34426417699]Search in Google Scholar
[12. Gargani L, Pang PS, Frassi F, et al. Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study. Cardiovascular Ultrasound. 2015. DOI: 10.1186/s12947-015-0033-4.10.1186/s12947-015-0033-4455882926337295]Search in Google Scholar